机译:一种新颖的双特异性配体定向毒素,旨在同时靶向人胶质母细胞瘤细胞上的EGFR和肿瘤新生脉管系统上的uPAR
Department of Therapeutic Radiology-Radiation Oncology, Section on Molecular Cancer Therapeutics, University of Minnesota Masonic Cancer Center, MMC: 367, Minneapolis, MN, 55455, USA;
Department of Therapeutic Radiology-Radiation Oncology, Section on Molecular Cancer Therapeutics, University of Minnesota Masonic Cancer Center, MMC: 367, Minneapolis, MN, 55455, USA;
Department of Therapeutic Radiology-Radiation Oncology, Section on Molecular Cancer Therapeutics, University of Minnesota Masonic Cancer Center, MMC: 367, Minneapolis, MN, 55455, USA;
Department of Therapeutic Radiology-Radiation Oncology, Section on Molecular Cancer Therapeutics, University of Minnesota Masonic Cancer Center, MMC: 367, Minneapolis, MN, 55455, USA;
Department of Pediatrics, University of Minnesota Masonic Cancer Center, Minneapolis, MN, USA;
Department of Therapeutic Radiology-Radiation Oncology, Section on Mol;
Immunotoxin; Pseudomonas exotoxin; Glioblastoma; Xenograft model; EGF;
机译:一种新颖的双特异性配体定向毒素,旨在同时靶向人胶质母细胞瘤细胞上的EGFR和肿瘤新脉管系统上的uPAR。
机译:用双特异性配体定向毒素靶向EGFR和uPAR对人横纹肌肉瘤,骨肉瘤和卵巢腺癌
机译:使用双特异性配体定向毒素DTEGF13和对流对流,可在颅内清除裸鼠的人胶质母细胞瘤脑瘤。
机译:双特异性抗体介导毒素的递送至肿瘤细胞
机译:B7H6 - 靶向双特异性T细胞参与诱导在Synegentic鼠淋巴瘤和黑色素瘤肿瘤模型中的免疫应答
机译:一种新的双特异性配体 - 定向毒素旨在在人胶质母细胞瘤细胞和肿瘤新生动物组织上同时靶向EGFR
机译:一种新的双特异性配体 - 定向毒素,旨在在人胶质母细胞瘤细胞和肿瘤新生动物组织上同时靶向EGFR